IS7118A - Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfnæmissjúkdómum - Google Patents

Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfnæmissjúkdómum

Info

Publication number: IS7118A
Authority: IS; Iceland
Prior art keywords: sup; sub; alkyl; optionally substituted; thienopyrimidinedione
Prior art date: 2001-07-28

Application number

IS7118A

Other languages

English (en)

Other versions

IS2598B (is

Inventor

Heulwen Reynolds Rachel

Howard Ingall Anthony

Tasneem Rasul Rukhsana

David Guile Simon

Edward Cooper Martin

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-28

Filing date

2004-01-19

Publication date

2004-01-19

2004-01-19 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-01-19 Publication of IS7118A publication Critical patent/IS7118A/is

2010-03-15 Publication of IS2598B publication Critical patent/IS2598B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Transplantation (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
AIDS & HIV (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)

IS7118A 2001-07-28 2004-01-19 Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma IS2598B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0118479.5A GB0118479D0 (en)	2001-07-28	2001-07-28	Novel compounds
PCT/GB2002/003399 WO2003011868A1 (en)	2001-07-28	2002-07-24	Thienopyrimidinediones and their use in the modulation of autoimmune disease

Publications (2)

Publication Number	Publication Date
IS7118A true IS7118A (is)	2004-01-19
IS2598B IS2598B (is)	2010-03-15

Family

ID=9919407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7118A IS2598B (is)	2001-07-28	2004-01-19	Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma

Country Status (25)

Country	Link
US (2)	US7384950B2 (is)
EP (1)	EP1414825B9 (is)
JP (1)	JP4456364B2 (is)
KR (1)	KR100897469B1 (is)
CN (1)	CN1324033C (is)
AR (1)	AR038000A1 (is)
AT (1)	ATE374204T1 (is)
AU (1)	AU2002319469B2 (is)
BR (1)	BR0211262A (is)
CA (1)	CA2453274A1 (is)
DE (1)	DE60222671T2 (is)
ES (1)	ES2292784T3 (is)
GB (1)	GB0118479D0 (is)
HK (1)	HK1065785A1 (is)
HU (1)	HUP0402336A3 (is)
IL (2)	IL159785A0 (is)
IS (1)	IS2598B (is)
MX (1)	MXPA04000677A (is)
MY (1)	MY138145A (is)
NO (1)	NO328713B1 (is)
NZ (1)	NZ530495A (is)
PL (1)	PL211351B1 (is)
RU (1)	RU2294937C9 (is)
WO (1)	WO2003011868A1 (is)
ZA (1)	ZA200400574B (is)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9801399D0 (sv)	1998-04-21	1998-04-21	Astra Pharma Prod	Method and apparatus for filling containers
GB0117583D0 (en) *	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
US7456184B2 (en)	2003-05-01	2008-11-25	Palatin Technologies Inc.	Melanocortin receptor-specific compounds
US7718802B2 (en)	2001-08-10	2010-05-18	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific piperazine compounds
US7732451B2 (en)	2001-08-10	2010-06-08	Palatin Technologies, Inc.	Naphthalene-containing melanocortin receptor-specific small molecule
US7655658B2 (en)	2001-08-10	2010-02-02	Palatin Technologies, Inc.	Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
WO2003013571A1 (en)	2001-08-10	2003-02-20	Palatin Technologies, Inc.	Peptidomimetics of biologically active metallopeptides
ATE323702T1 (de)	2002-08-06	2006-05-15	Astrazeneca Ab	Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
US6890923B2 (en) *	2002-12-16	2005-05-10	Astrazeneca Ab	Compounds
SE0300119D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
SE0300120D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
BRPI0406782A (pt) *	2003-01-17	2006-01-17	Astrazeneca Ab	Derivados de tieno-piridazinonas e seu uso na modulação de doenças autoimunes
CA2518398A1 (en) *	2003-03-10	2004-09-23	Schering Corporation	Heterocyclic kinase inhibitors: methods of use and synthesis
US7968548B2 (en) *	2003-05-01	2011-06-28	Palatin Technologies, Inc.	Melanocortin receptor-specific piperazine compounds with diamine groups
US7727991B2 (en)	2003-05-01	2010-06-01	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific single acyl piperazine compounds
US7727990B2 (en)	2003-05-01	2010-06-01	Palatin Technologies, Inc.	Melanocortin receptor-specific piperazine and keto-piperazine compounds
CN1925855B (zh)	2003-12-19	2010-06-16	普莱希科公司	开发Ret调节剂的化合物和方法
US7550602B1 (en)	2004-01-14	2009-06-23	Palatin Technologies, Inc.	Small molecule compositions for sexual dysfunction
US7709484B1 (en)	2004-04-19	2010-05-04	Palatin Technologies, Inc.	Substituted melanocortin receptor-specific piperazine compounds
US7498342B2 (en)	2004-06-17	2009-03-03	Plexxikon, Inc.	Compounds modulating c-kit activity
US7732472B2 (en) *	2004-08-18	2010-06-08	Merck & Co., Inc.	Mitotic kinesin inhibitors
MX2007014377A (es)	2005-05-17	2008-02-06	Plexxikon Inc	Inhibidores de proteina cinasa de derivados de pirrol (2,3-b) piridina.
ATE518860T1 (de)	2005-06-22	2011-08-15	Plexxikon Inc	Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren
US7834017B2 (en)	2006-08-11	2010-11-16	Palatin Technologies, Inc.	Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
WO2008063888A2 (en)	2006-11-22	2008-05-29	Plexxikon, Inc.	Compounds modulating c-fms and/or c-kit activity and uses therefor
BRPI0814423B1 (pt)	2007-07-17	2022-04-19	Plexxikon, Inc	Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
RU2341527C1 (ru) *	2007-07-17	2008-12-20	Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия"	Аннелированные азагетероциклы, включающие пиримидиновый фрагмент, способ их получения и ингибиторы pi3k киназ
RU2345996C1 (ru) *	2007-07-17	2009-02-10	Андрей Александрович Иващенко	Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
EP2245016A1 (en) *	2008-01-22	2010-11-03	Boehringer Ingelheim International GmbH	Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture
SG184767A1 (en) *	2009-03-23	2012-10-30	Glenmark Pharmaceuticals Sa	Furopyrimidinedione derivatives as trpa1 modulators
CN110269838A (zh)	2009-04-03	2019-09-24	豪夫迈罗氏公司	丙烷-1-磺酸{3-[5-(4-氯-苯基)-1H-吡咯并[2,3-b]吡啶-3-羰基]-2,4-二氟-苯基}-酰胺组合物及其用途
US20110112127A1 (en)	2009-11-06	2011-05-12	Plexxikon, Inc.	Compounds and methods for kinase modulation, and indications therefor
BR112013020041B1 (pt)	2011-02-07	2021-11-23	Plexxikon, Inc	Compostos e composições para a modulação de quinases e uso dos mesmos
AR085279A1 (es)	2011-02-21	2013-09-18	Plexxikon Inc	Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
JP5990980B2 (ja) *	2012-04-02	2016-09-14	大日本印刷株式会社	オランザピンの中間体の製造方法
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6469014B1 (en) *	1997-05-28	2002-10-22	Astrazeneca Ab	Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
SE9702001D0 (sv) *	1997-05-28	1997-05-28	Astra Pharma Prod	Novel compounds
PL340836A1 (en)	1997-12-05	2001-02-26	Astrazeneca Uk Ltd	Novel compounds
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
PT1107973E (pt) *	1998-08-28	2004-03-31	Astrazeneca Ab	Novas tieno¬2,3-d\| pirimidinodionas processo para a sua preparacao e sua utilizacao em terapia
GB0117583D0 (en) *	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
BRPI0406782A (pt) *	2003-01-17	2006-01-17	Astrazeneca Ab	Derivados de tieno-piridazinonas e seu uso na modulação de doenças autoimunes
SE0300119D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
SE0300120D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds

2001
- 2001-07-28 GB GBGB0118479.5A patent/GB0118479D0/en not_active Ceased
2002
- 2002-07-24 RU RU2004102392/04A patent/RU2294937C9/ru not_active IP Right Cessation
- 2002-07-24 DE DE60222671T patent/DE60222671T2/de not_active Expired - Lifetime
- 2002-07-24 ES ES02749055T patent/ES2292784T3/es not_active Expired - Lifetime
- 2002-07-24 PL PL369232A patent/PL211351B1/pl not_active IP Right Cessation
- 2002-07-24 EP EP02749055A patent/EP1414825B9/en not_active Expired - Lifetime
- 2002-07-24 US US10/483,162 patent/US7384950B2/en not_active Expired - Fee Related
- 2002-07-24 AU AU2002319469A patent/AU2002319469B2/en not_active Ceased
- 2002-07-24 JP JP2003517059A patent/JP4456364B2/ja not_active Expired - Fee Related
- 2002-07-24 CN CNB028152506A patent/CN1324033C/zh not_active Expired - Fee Related
- 2002-07-24 BR BR0211262-0A patent/BR0211262A/pt not_active IP Right Cessation
- 2002-07-24 WO PCT/GB2002/003399 patent/WO2003011868A1/en active IP Right Grant
- 2002-07-24 AT AT02749055T patent/ATE374204T1/de not_active IP Right Cessation
- 2002-07-24 MX MXPA04000677A patent/MXPA04000677A/es active IP Right Grant
- 2002-07-24 NZ NZ530495A patent/NZ530495A/en not_active IP Right Cessation
- 2002-07-24 KR KR1020047001192A patent/KR100897469B1/ko not_active IP Right Cessation
- 2002-07-24 HU HU0402336A patent/HUP0402336A3/hu unknown
- 2002-07-24 IL IL15978502A patent/IL159785A0/xx unknown
- 2002-07-24 CA CA002453274A patent/CA2453274A1/en not_active Abandoned
- 2002-07-26 AR ARP020102842A patent/AR038000A1/es active IP Right Grant
- 2002-07-26 MY MYPI20022835A patent/MY138145A/en unknown
2004
- 2004-01-08 IL IL159785A patent/IL159785A/en not_active IP Right Cessation
- 2004-01-19 IS IS7118A patent/IS2598B/is unknown
- 2004-01-26 ZA ZA200400574A patent/ZA200400574B/en unknown
- 2004-01-27 NO NO20040364A patent/NO328713B1/no not_active IP Right Cessation
- 2004-10-28 HK HK04108484A patent/HK1065785A1/xx not_active IP Right Cessation
2008
- 2008-04-29 US US12/111,792 patent/US20080207642A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1065785A1 (en)	2005-03-04
US20080207642A1 (en)	2008-08-28
IL159785A0 (en)	2004-06-20
MXPA04000677A (es)	2004-04-05
DE60222671D1 (de)	2007-11-08
KR20040017355A (ko)	2004-02-26
JP4456364B2 (ja)	2010-04-28
RU2294937C2 (ru)	2007-03-10
AR038000A1 (es)	2004-12-22
IL159785A (en)	2009-11-18
US20040254198A1 (en)	2004-12-16
GB0118479D0 (en)	2001-09-19
WO2003011868A1 (en)	2003-02-13
ATE374204T1 (de)	2007-10-15
IS2598B (is)	2010-03-15
RU2004102392A (ru)	2005-07-10
PL369232A1 (en)	2005-04-18
RU2294937C9 (ru)	2007-07-20
EP1414825A1 (en)	2004-05-06
NZ530495A (en)	2005-07-29
JP2004538316A (ja)	2004-12-24
NO328713B1 (no)	2010-05-03
EP1414825B9 (en)	2009-09-16
MY138145A (en)	2009-04-30
AU2002319469B8 (en)	2003-02-17
EP1414825B1 (en)	2007-09-26
BR0211262A (pt)	2004-07-20
CN1538970A (zh)	2004-10-20
HUP0402336A3 (en)	2008-09-29
DE60222671T2 (de)	2008-06-26
KR100897469B1 (ko)	2009-05-14
CN1324033C (zh)	2007-07-04
ES2292784T3 (es)	2008-03-16
AU2002319469B2 (en)	2007-08-09
HUP0402336A2 (hu)	2005-02-28
CA2453274A1 (en)	2003-02-13
ZA200400574B (en)	2005-04-26
US7384950B2 (en)	2008-06-10
PL211351B1 (pl)	2012-05-31
NO20040364L (no)	2004-03-29

Publication	Publication Date	Title
IS7118A (is)	2004-01-19	Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfnæmissjúkdómum
DE60213609D1 (de)	2006-09-14	THIENOi2,3-döPYRIMIDINEDIONES ALS INHIBITOREN VON T-ZELLEN-PROLIFERATION
HK1081958A1 (en)	2006-05-26	Thienopyridazinone derivative as modulators of autoimmune diseases
DE60320012D1 (de)	2008-05-08	Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen
DK0687268T3 (da)	1998-10-12	Spiroazacykliske derivater som substans P-antagonister
EA200600358A1 (ru)	2006-08-25	Фенил- или пиридиламидные соединения в качестве антагонистов простагландина е2
CY1110240T1 (el)	2015-01-14	Νεα παραγωγα 2η-πυριδαζινο-3-ονης, φαρμακευτικες συνθεσεις που τα περιεχουν και μεθοδος για την παρασκευη του δραστικου συστατικου
EA200600811A1 (ru)	2006-10-27	НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
HUP9901074A2 (hu)	2001-04-28	Tetrahidropirán és tetrahidrotiopirán aminosavak és ezeket tartalmazó gyógyszerkészítmények
MXPA05007496A (es)	2005-09-21	Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes.
DE60214591D1 (en)	2006-10-19	Pyrazolpyrimidinfungizide
HUP0203509A2 (hu)	2003-03-28	Triciklusos pirazolkarbonsav-származékok, a vegyületek előállítása és a vegyületeket tartalmazó gyógyászati készítmények
SE0201659D0 (sv)	2002-05-31	Modified release pharmaceutical formulation
DE602004009200D1 (de)	2007-11-08	Tetrahydrochinazolinderivate als cfr-antagonisten
EA200100090A2 (ru)	2001-08-27	Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
SE0203303D0 (sv)	2002-11-07	Novel Compounds
BRPI0415109A (pt)	2006-11-28	compostos de 1-[2-(4-hidroxifenil)-2-hidroxietil]-piperidin-4-ol como antagonistas de receptor de nmda
IL165220A0 (en)	2005-12-18	Novel compounds, their use and preparation
NO20023041D0 (no)	2002-06-21	Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
DE69725167D1 (de)	2003-10-30	N-benzolsulfonyl-l-prolin derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung
DE60119383D1 (de)	2006-06-08	Farnesyltransferasehemmende 4-heterocyclylchinolin- und chinazolinderivate
ATE268771T1 (de)	2004-06-15	Verfahren zur herstellung von pyrazolopyridinderivaten
NZ535183A (en)	2006-03-31	Fused bicyclic pyrimidine derivatives
GB0114699D0 (en)	2001-08-08	Organic compounds
UA70917C2 (uk)	2004-11-15	Похідні оксадіазину, інсектицидна композиція та спосіб боротьби з комахами